Skip to main content

Caudalíe Partners With Harvard Medical School on a New Patent

Caudalíe teamed with Harvard Medical School on a new patent to lift and firm skin.

Caudalíe has gone back to school for its latest innovation, the Resveratrol Lift collection.

Developed in collaboration with Harvard Medical School, the four-piece assortment includes a patented combination of vine resveratrol and micro hyaluronic acid to stimulate the production of collagen and elastin fibers. It is also designed to boost the skin’s natural production of hyaluronic acid.

“[The combination of vine resveratrol and micro hyaluronic acid] boosts a gene called HAS2 by more than 200 percent,” said Mathilde Thomas, cofounder of Caudalíe. “The patent is going to firm thanks to resveratrol and replump and add volume thanks to hyaluronic acid.”

Dr. David Sinclair of Harvard Medical School, who Thomas heard about from Professor Joseph Vercauteren, Caudalíe’s scientific adviser, uncovered the synergy between resveratrol and micro hyaluronic acids.

“Our pillar is resveratrol,” Sinclair said. “Caudalíe scientists and our lab are constantly researching how it works on the skin and understanding ways to improve it. Today we’ve developed a superior, breakthrough with Caudalíe’s stabilized vine resveratrol and the hyaluronic acid complex. The combination of the two drastically improves the efficacy of resveratrol alone.”

You May Also Like

The Resveratrol Lift collection includes a serum, $82; eye balm, $62; moisturizer, $66, and night cream, $76, and will be sold beginning in September at Caudalíe boutiques,, Sephora and

Although Thomas wouldn’t talk financials, industry sources estimate that the Resveratrol Lift Collection could do $10 million in the U.S. at retail in its first year on shelves.